SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,513,451 | -75.3% | 4,500,000 | -75.8% | 0.00% | -100.0% |
| Q4 2022 | $18,285,228 | +101.1% | 18,600,000 | +100.0% | 0.00% | 0.0% |
| Q3 2022 | $9,092,000 | +7.2% | 9,300,000 | +6.3% | 0.00% | 0.0% |
| Q2 2022 | $8,481,000 | -12.0% | 8,750,000 | -11.2% | 0.00% | – |
| Q1 2022 | $9,636,000 | -11.7% | 9,850,000 | -10.5% | 0.00% | -100.0% |
| Q4 2021 | $10,909,000 | +11.8% | 11,000,000 | +11.1% | 0.00% | 0.0% |
| Q3 2021 | $9,754,000 | -5.0% | 9,900,000 | -4.8% | 0.00% | 0.0% |
| Q2 2021 | $10,266,000 | -6.1% | 10,400,000 | -8.0% | 0.00% | 0.0% |
| Q1 2021 | $10,934,000 | +30.8% | 11,300,000 | +27.7% | 0.00% | 0.0% |
| Q4 2020 | $8,358,000 | +2.0% | 8,850,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $8,195,000 | -6.2% | 8,850,000 | -10.6% | 0.00% | 0.0% |
| Q2 2020 | $8,740,000 | -9.8% | 9,900,000 | -16.8% | 0.00% | 0.0% |
| Q1 2020 | $9,689,000 | -8.1% | 11,900,000 | +2.4% | 0.00% | 0.0% |
| Q4 2019 | $10,548,000 | -2.7% | 11,625,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $10,837,000 | -3.9% | 11,625,000 | +0.9% | 0.00% | 0.0% |
| Q2 2019 | $11,276,000 | – | 11,525,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 71,162 | $69,799,000 | 4.72% |
| ZAZOVE ASSOCIATES LLC | 27,692,000 | $27,021,000 | 2.38% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 61,727,000 | $60,252,000 | 1.17% |
| SHENKMAN CAPITAL MANAGEMENT INC | 7,637,000 | $7,524,000 | 0.85% |
| NN Investment Partners Holdings N.V. | 38,700,000 | $37,743,000 | 0.30% |
| CAMDEN ASSET MANAGEMENT L P /CA | 5,825,000 | $5,684,000 | 0.18% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 4,479,000 | $4,384,000 | 0.16% |
| Lombard Odier Asset Management (Europe) Ltd | 2,005,000 | $1,905,000 | 0.16% |
| PRUDENTIAL PLC | 41,809,000 | $40,973,000 | 0.12% |
| Calamos Advisors LLC | 22,303,000 | $21,829,000 | 0.12% |